Company / Operating Margin
Voyager Therapeutics, Inc. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
48.8%
FY2025
5-year range
-196.8% / 48.8%
FY2021-FY2025
Trend
+139.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has fluctuated over the past 10 years, ranging from -1195.6% in FY2020 to 48.8% in FY2025.
Based on SEC 10-K filings.
48.8% in FY2025 with a 5-year CAGR of +1244.4%.
Improved from -196.8% to 48.8% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +32.8pp
- 5-Year Change
- +1244.4pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin increased 139.3% year-over-year.
- Lowest operating margin in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.34 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 48.8% | +139.3% |
| FY2024 | -124.3% | +36.8% |
| FY2023 | -196.8% | -1329.8% |
| FY2022 | 16.0% | +132.3% |
| FY2021 | -49.5% | +95.9% |
| FY2020 | -1195.6% | -68.6% |
| FY2019 | -709.1% | -144.1% |
| FY2018 | -290.4% | -148.5% |
| FY2017 | -116.9% | -41.0% |
| FY2016 | -82.9% | +43.3% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026